Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Research Team Develops TB/HIV Combination Vaccine

publication date: May 24, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
A team of China researchers has developed a new DNA vaccine that simultaneously protected against tuberculosis and HIV in animal tests. M. tuberculosis is the cause of death in about 25% of all AIDS deaths. The disease is latent in many people; however, it is 20-30 times more likely to become active in HIV patients. The research group, led by Sidong Xiong of Shanghai’s Fudan University, published its results in the May 2012 issue of Clinical and Vaccine Immunology. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners